A seismic shift is underway in American healthcare. As cannabis legalization continues to expand across the nation, peer-reviewed research is confirming what many California consumers have known for years—legal access to cannabis is fundamentally changing how people manage their health, and it’s saving money in the process.
Published in the prestigious journal Health Economics in May 2025, the latest study from researchers at Bowling Green State University and Illinois State University delivers compelling evidence: recreational cannabis legalization is associated with a 6% reduction in prescription drug claims among working-age adults in small group insurance markets.
Key Research Findings
Multiple peer-reviewed studies reveal significant healthcare cost reductions
Reduction in prescription drug claims after recreational legalization
Of patients reduced or stopped opioid painkillers with cannabis
Annual savings per enrollee in prescription drug claims
Prescription Drug Reductions by Condition
How recreational cannabis legalization impacts pharmaceutical usage across key medical categories (Medicaid data 2011-2019)
-12%
-11%
-11%
-11%
-10%
-8%
Source: Health Economics Journal, NORML Research Archives, Journal of Psychoactive Drugs
Why Cannabis Is Emerging as an Alternative
Research highlights key advantages driving the prescription substitution trend
Superior Safety Profile
Cannabis possesses a safety profile either comparable or superior to many prescription medicines like opioids. Zero fatal overdoses have been directly attributed to cannabis, while opioids claim over 28,000 lives annually.
Fewer Side Effects
92% of patients surveyed reported experiencing more tolerable side effects with cannabis compared to opioid medications alone. Unlike NSAIDs that cause GI bleeding or acetaminophen’s liver damage risks, cannabis offers gentler alternatives.
No Tolerance Escalation
Unlike opioids where patients develop tolerance requiring ever-higher doses, cannabis users generally maintain stable dosing without the dangerous escalation cycle that leads to increased overdose risk.
Multi-Symptom Relief
Cannabis addresses multiple conditions simultaneously—pain, anxiety, sleep, and mood—potentially replacing several prescriptions with one natural plant-based solution. 47% of patients report using it for combined pain and mental health conditions.
Accessible Without Barriers
Recreational cannabis laws provide broader access without requiring medical diagnoses or physician recommendations, making natural wellness options available to more people who might benefit from plant-based alternatives.
Proven Efficacy
Meta-analysis across 47 randomized controlled trials shows medium-to-large effect of cannabinoids to reduce pain, with significant evidence for 30% pain reduction. 80% of patients surveyed found cannabis “very or extremely helpful.”
Cannabis vs. Traditional Prescriptions
A comparison of key factors influencing patient choices
What Californians Are Saying
Real experiences from cannabis consumers across the Golden State
“After ten years on opioids for back pain, I was terrified of the dependency. Since switching to cannabis two years ago, I’ve completely stopped my pain medications. My doctor says my liver function tests have never looked better.”
“I was taking Xanax for anxiety and Ambien for sleep. The groggy mornings were affecting my work. With the right cannabis products, I’ve been able to reduce both prescriptions by 75%. I actually wake up feeling refreshed.”
“The VA had me on a cocktail of medications. Depression, anxiety, pain—different pills for each. Cannabis lets me address all of it naturally. My prescription costs dropped from $400 a month to almost nothing.”
Understanding the Research
The May 2025 study analyzed prescription drug claims from small and large group health insurance plans for working-age enrollees between 2010 and 2019. Using a difference-in-differences framework, researchers found statistically significant reductions in prescription drug expenditures specifically concentrated in small group insurance markets.
Interestingly, the study did not find similar reductions among enrollees in large group insurance plans. Researchers speculate this is because larger companies typically impose mandatory marijuana testing among their employees, creating a barrier to cannabis substitution even in legal states.
Key Takeaway: “The legalization of cannabis offers a potential substitute to traditional prescription drugs and alternative methods for health maintenance,” the study’s authors concluded. This aligns with previous research showing cannabis legalization is associated with lower health insurance premiums and reduced Medicaid spending.
These findings build upon earlier research from Cornell University and Indiana University that found recreational cannabis laws are associated with reductions in Medicaid prescription volumes of 11-12% for anxiety, depression, sleep, and psychosis medications, and 8-10% for pain and seizure drugs respectively.
What This Means for California Consumers
States with medical marijuana laws—California leading since 1996
States with adult-use recreational cannabis laws
Lower opioid prescribing rate in states with medical cannabis
As a pioneer in cannabis legalization, California consumers have access to a mature, regulated market with diverse product options. Whether you’re exploring cannabis for pain management, sleep support, anxiety relief, or general wellness, understanding these research findings empowers you to make informed decisions about your health journey.
Important Information
This article is for informational purposes only and does not constitute medical advice. Always consult with your healthcare provider before making changes to your medication regimen. Cannabis may not be appropriate for everyone, and the decision to use cannabis should be made in consultation with qualified medical professionals. Individual results may vary. Cannabis products are intended for use only by adults 21 and older in legal jurisdictions.
Research Sources
- Smith, R.A., et al. (2025). “The effects of medical and recreational cannabis laws on prescription drug claims in commercial group insurance markets.” Health Economics.
- Raman, S. & Bradford, A. (2022). “Recreational Cannabis Legalizations Associated with Reductions in Prescription Drug Utilization Among Medicaid Enrollees.” Health Economics.
- Bachhuber, M., et al. (2019). “Use of Cannabis to Relieve Pain and Promote Sleep by Customers at an Adult Use Dispensary.” Journal of Psychoactive Drugs.
- Piper, B.J., et al. (2017). “Substitution of medical cannabis for pharmaceutical agents for pain, anxiety, and sleep.” Journal of Psychopharmacology.
- Bradford, A.C. & Bradford, W.D. (2016, 2017). “Medical Marijuana Laws Reduce Prescription Medication Use.” Health Affairs.
- NORML Fact Sheet: Relationship Between Marijuana and Opioids (2019-2025).
